Acadia Pharmaceuticals (ACAD) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 150%. A quarter ago, it was expected that this drugmaker would post earnings of $0.32 per share when it actually produced earnings of $0.28, delivering a surprise of -12.50%.Over the last four quarters, the comp ...